About Certara
Certara is a publicly listed company based in Princeton (United States) founded in 2008, and was acquired by EQT in July 2017. Provider of a platform for in silico drug discovery and consulting services. The company has 1,550 employees. Certara has completed 10 acquisitions, including Analytica Laser, Applied BioMath and BaseCase. Its chief executive, as recorded, is William Feehery. Its website certara.com draws about 98 thousand monthly visits. Its Indian entity Certara Software India Private Limited reported revenue of ₹15.29 Cr. Certara offers products and services including Phoenix™, Pinnacle 21, Simcyp™, and GlobalSubmit™. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its competitors include Insitro, HotSpot Therapeutics and GRO Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
Certara was founded in 2008 and is headquartered in Princeton, United States. Operations focus on the biosimulation sector, where software solutions for molecular modeling, pharmacokinetic and pharmacodynamic simulations, clinical trial modeling, and scientific informatics are developed. Drug development consulting and medical writing services are also delivered to support pharmaceutical research and regulatory needs.
- Indian entity revenue₹15.29 Cr
FY 2025 · +8% YoY
- Indian entity net profit₹76.6 Lakh
FY 2025 · 5% margin
- Indian entity EBITDA₹2.34 Cr
FY 2025 · 15% margin
- InvestorsGolub Capital
& 5 more
- Employee Count1,550
- Investments & AcquisitionsAnalytica Laser
& 9 more
- Acquired by
Associated legal entities of Certara
Certara operates through Certara Software India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Certara Software India Private Limited CIN U72900KA2012PTC064356 | Active | 12 Jun 2012 | Bangalore, Karnataka | ₹15.3 Cr | 44 | 2 | View details |
Products & Services of Certara
Certara offers a comprehensive portfolio of products and services, including Phoenix™, Pinnacle 21, Simcyp™, and GlobalSubmit™.
Tool for PK, PD, and toxicokinetic analysis and modeling
Platform for data standardization and validation in drug development
System for predicting drug behavior in diverse populations
Solution for publishing and transmitting eCTD submissions
Apps and channels of Certara
its YouTube channel Certara has 5.64K subscribers and 30 videos.
Videos from Certara
The most watched videos on Certara's YouTube channel, Certara (5.64K subscribers). Click a video to play it here.
More on Certara.
Funding Insights of Certara
- Total Rounds 6
- First Round $88.5M
(Dec 2013)
- Investors Count 3
All 6 funding rounds of Certara with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2021 | Grant | – | – | ||
| Jul 2021 | $250M | Post-IPO | – | – | |
| Jun 2021 | $851,895 | Grant | – | – | |
| Nov 2016 | $334,381 | Grant | – | – | |
| Jan 2016 | $988,909 | Grant | – | – | |
| Dec 2013 | $88.5M | Debt – Conventional | – | – | – |
6 investors in total: 6 institutional.
Investors in Certara
Certara has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Golub Capital, EQT and Mubadala.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments target specialty industrials and healthcare sectors. | 2000 | arsenalcapital.com | New York, United States | |
EQT is recognized as a global investment organization focused on value creation. | 1994 | eqtgroup.com | Stockholm, Sweden | |
The U.S. Food and Drug Administration is tasked with regulating food, drugs, and medical products. | fda.gov | United States | ||
Sovereign wealth fund of United Arab Emirates | 2002 | mubadala.com | Abu Dhabi, United Arab Emirates | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Private debt investments are managed for U.S. middle market companies. | 1994 | golubcapital.com | Chicago, United States |
Investor details for Certara
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Certara Software India Private Limited (Certara)
Certara Software India Private Limited is the primary company behind Certara. The board of Certara Software India Private Limited currently have 2 directors; the longest-serving is Krishnan Arumugam, appointed in 2018. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Krishnan Arumugam DIN 06510611 | Director | 20 Sep 2018 | 8 yrs 1 mo | Certara Software India Private Limited |
| Daniel Desmond Corcoran DIN 10815864 | Additional Director | 31 Oct 2024 | 2 yrs | Certara Software India Private Limited |
People of Certara
20 people are tracked at Certara (11 in leadership, 8 in board & advisors, 1 in team); the tracked headcount is 1,550.
| Name | Role | Group |
|---|---|---|
William Feehery | CEO | Leadership |
Max Kanevsky | Chief Technology Officer | Leadership |
Patrick F. Smith | President, Certara Drug Development Solutions | Leadership |
John E. Gallagher III | CFO | Leadership |
| Chief Counsel | Leadership | |
Rona Anhalt | Chief Human Resources Officer | Leadership |
William F. Feehery | CEO | Leadership |
Leif E. Pedersen | President & CCO | Leadership |
lucas Hixson | Director of Corporate Strategy | Leadership |
Robert Aspbury | President, Certara Scientific Software | Leadership |
Sheila Rocchio | Chief Marketing Officer | Leadership |
Stephen McLean | Director | Board & advisors |
James E. Cashman III | Chairman | Board & advisors |
Cynthia Collins | Director | Board & advisors |
Nancy Killefer | Director | Board & advisors |
David Spaight | Director | Board & advisors |
Matthew Walsh | Director | Board & advisors |
Rosemary Crane | Director | Board & advisors |
Eran Broshy | Director | Board & advisors |
Ron DiSantis | SVP, Corporate Development | Team |
Complete people profiles for Certara
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Certara
Certara is a publicly listed company on the NASDAQ with ticker symbol CERT in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date11 Dec 2020
- Listed onNASDAQ: CERT
- Listed entityCertara, Inc.
- Exchange sectorTechnology services
- ISINUS15687V1098
- Share price$9.60 (+3.9% on the day) · 2026-10-13
- Market capitalisation$1.46B
- Price to earnings135.9
- EPS (diluted, trailing year)$-0.02
- Volume (last session)2,905,637
Financials of Certara
Figures of Certara Software India Private Limited, the primary company behind Certara, for FY 2025. Revenue was ₹15.29 Cr (+8% year on year). Net profit was ₹76.6 Lakh (5% margin). EBITDA was ₹2.34 Cr (15% margin). Revenue has grown at a compounded annual rate of +20% over three years and +25% over five years.
- ₹15.29 CrRevenue · FY 2025 · +8% YoY
- ₹76.6 LakhNet profit · 5% margin
- ₹2.34 CrEBITDA · 15% margin
- ₹1 LakhPaid-up capital
- 44Employees (provident fund records)
- +20%Revenue CAGR, 3 years
- +25%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $418.8M | -$1.6M | $100.9M |
| 2024 | $385.1M | -$12.1M | $86.8M |
| 2023 | $354.3M | -$55.4M | $70.1M |
| 2022 | $335.6M | $14.7M | $88.4M |
| 2021 | $286.1M | -$13.3M | $72.7M |
Balance sheet, profit and loss, cash flow and ratios of Certara Software India Private Limited are on its company page.
Detailed financial statements for Certara
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Certara
Certara has strategically engaged in corporate development activities, having acquired 10 companies. Notable acquisitions include Analytica Laser, Applied BioMath and BaseCase.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cheminformatics software platforms, applications and services for bio technology and pharmaceutical industries. | chemaxon.com | Budapest, Hungary | 1998 | Jul 2024 | •••• | |
Systems biology and pharmacology modeling services to aid drug discovery and development | appliedbiomath.com | Cambridge, United States | 2013 | Dec 2023 | •••• | |
Deep learning platform is provided for life sciences market research. | vyasa.com | Newburyport, United States | 2016 | Jan 2023 | •••• | |
Clean and validate Define file for compliance | pinnacle21.com | Plymouth Meeting, United States | 2005 | Aug 2021 | $310M | |
Regulatory documentation, medical writing, marketing, and translation services are provided. | insightmw.com | Kidlington, United Kingdom | 2001 | Jun 2021 | •••• | |
Pharmacometrics modeling workbench software is developed for pharmaceutical applications. | pirana-software.com | Denekamp, Netherlands | 2011 | Sep 2018 | •••• | |
Research consultancy services are provided to clients across sectors. | analytica-laser.com | London, United Kingdom | 1997 | Apr 2018 | •••• | |
Sales and marketing solutions for life sciences industry | basecase.com | Berlin, Germany | 2007 | Feb 2018 | •••• | |
Clinical pharmacology consulting services are provided for drug development. | d3medicine.com | Parsippany Troy Hills, United States | 2012 | Sep 2016 | •••• | |
Offers medical and regulatory writing services (including an AI assisted medical writing service) | synchrogenix.com | Wilmington, United States | 1986 | Apr 2014 | •••• |
Complete acquisition details for Certara
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Certara
16 dated milestones of Certara across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Certara is founded.
- Exit Acquired by Arsenal Capital Partners.
- Funding First funding round of $88.5M.
- Acquisition Acquires Synchrogenix.
- Acquisition Acquires D3 Medicine.
- Exit Acquired by EQT.
- Acquisition Acquires BaseCase.
- Acquisition Acquires Analytica Laser.
- Acquisition Acquires Pirana Software & Consulting.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Insight Medical Writing.
- Acquisition Acquires Pinnacle 21.
- Funding Latest funding round, Grant,.
- Acquisition Acquires Vyasa.
- Acquisition Acquires Applied BioMath.
- Acquisition Acquires ChemAxon.
Competitors of Certara
Certara has 3 listed competitors in our database, 3 of them funded. They include Insitro, HotSpot Therapeutics and GRO Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| insitro.com | 2018 | San Francisco, United States | $643.21M | 257 | An AI-enabled platform is developed for infectious disease treatment. | |
| hotspotthera.com | 2017 | Boston, United States | $210M | 37 | Developer of a platform for protein function analysis | |
| grobio.com | 2016 | Boston, United States | $91.15M | 22 | Synthetic biology tools are developed via genetic code recoding techniques. |
Detailed competitors of Certara
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Certara
The website of Certara (certara.com) receives about 98.2K visits a month and ranks #495,649 among all websites worldwide, #915 in Pharmacy.
- Monthly visits98.2K
▲ 22.1% vs previous month
- Unique visitors38.3K
per month
- Global rank#495,649
among all websites
- Category rank#915
Health · Pharmacy
- Bounce rate47%
- Pages per visit1.6
- Average visit31 sec
- DevicesDesktop 39% · Mobile 61%
Websites whose visitors overlap most with Certara. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
boomer.org | boomer.org | 100% | #1,678,721 | – | |
amcp.org | amcp.org | 100% | #735,476 | – | |
ascpt.org | ascpt.org | 100% | #1,430,900 | – | |
| pharmaceutical-technology.com | 100% | #316,052 | View details | ||
| fip.org | 100% | #344,296 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Certara
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Certara (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Certara
Complete news archive for Certara
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Certara
Certara was founded in 2008 and raised its 1st funding round 5 years after it was founded.
Certara is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.
William Feehery is the CEO of Certara, as recorded in our data.
Certara has 1,550 employees.
The primary company behind Certara, Certara Software India Private Limited, reported revenue of ₹15.29 Cr for FY 2025, up 8% year on year.
Certara was founded in 2008 and is headquartered in Princeton, United States. Operations focus on the biosimulation sector, where software solutions for molecular modeling, pharmacokinetic and pharmacodynamic simulations, clinical trial modeling, and scientific informatics are developed. Drug development consulting and medical writing services are also delivered to support pharmaceutical research and regulatory needs.
Certara's top competitors include Insitro, HotSpot Therapeutics and GRO Biosciences.
Certara offers Phoenixâ„¢, Pinnacle 21, Simcypâ„¢, and GlobalSubmitâ„¢.
Yes, Certara is publicly traded on NASDAQ under the ticker symbol CERT.
Certara has made 10 acquisitions, including Analytica Laser, Applied BioMath, and BaseCase.
Certara has 6 investors. Key investors include Golub Capital, EQT, Mubadala, Arsenal Capital Partners, and European Union.
Certara operates through Certara Software India Private Limited.